Collaterals at angiography and outcomes in the Interventional Management of Stroke (IMS) III trial

…, TG Jovin, P Khatri, R von Kummer, RM Sugg… - Stroke, 2014 - Am Heart Assoc
Background and Purpose— Endovascular strategies provide unique opportunity to correlate
angiographic measures of collateral circulation at the time of endovascular therapy. We …

A pilot randomized clinical safety study of sonothrombolysis augmentation with ultrasound-activated perflutren-lipid microspheres for acute ischemic stroke

…, M Ribo, VK Sharma, AY Lao, G Tsivgoulis, RM Sugg… - Stroke, 2008 - Am Heart Assoc
Background and Purpose— Ultrasound transiently expands perflutren-lipid microspheres (μS),
transmitting energy momentum to surrounding fluids. We report a pilot safety/feasibility …

The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study

…, Z Chen, MH Rahbar, C Balucani, K Barlinn, RM Sugg… - Stroke, 2012 - Am Heart Assoc
… TCD and CT angiography studies were reviewed and adjudicated by central readers (ZG,
RM, and AMD) who were unaware of the patients' clinical course. In MCA strokes, …

The Society of Vascular and Interventional Neurology (SVIN) mechanical thrombectomy registry: methods and primary results

…, BP Mehta, JE Sessa, RM Sugg… - Stroke: Vascular and …, 2022 - Am Heart Assoc
Background A better understanding of real‐world practice patterns in the endovascular
treatment for large vessel occlusion acute ischemic stroke is needed. Here, we report the …

Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke?

…, NR Gonzales, RU Weir, AM Khaja, RM Sugg… - Stroke, 2007 - Am Heart Assoc
Background and Purpose— The optimal approach for acute ischemic stroke patients who do
not respond to intravenous recombinant tissue plasminogen activator (IV rt-PA) is uncertain. …

Argatroban tPA stroke study: study design and results in the first treated cohort

RM Sugg, JK Pary, K Uchino, S Baraniuk… - Archives of …, 2006 - jamanetwork.com
Background The benefit of intravenous recombinant tissue plasminogen activator (rtPA) in
acute stroke is linked to clot lysis and artery recanalization. Argatroban is a direct thrombin …

Cerebral mycotic aneurysms treated with a neuroform stent: technical case report

RM Sugg, R Weir, DG Vollmer, ED Cacayorin - Neurosurgery, 2006 - journals.lww.com
OBJECTIVE AND IMPORTANCE: We describe the first documented endovascular treatment
of proximal intracranial mycotic aneurysms by a self-expanding, flexible, dedicated, …

Is mechanical embolectomy performed in nonanesthetized patients effective?

RM Sugg, AS Jackson, W Holloway… - American journal …, 2010 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: In centers performing endovascular treatment for patients
with AIS, there is variability in placing patients under general anesthesia. Nonanesthetized …

Intra-arterial reteplase compared to urokinase for thrombolytic recanalization in acute ischemic stroke

RM Sugg, EA Noser, HM Shaltoni… - American journal …, 2006 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Reteplase (RP) and urokinase (UK) are being used “off-label”
to treat acute ischemic stroke. The safety and efficacy of intra-arterial RP or UK in the …

Endovascular recanalization of internal carotid artery occlusion in acute ischemic stroke

RM Sugg, MD Malkoff, EA Noser… - American journal …, 2005 - Am Soc Neuroradiology
BACKGROUND: Endovascular therapy (ET) of internal carotid artery (ICA) stenosis is
equivalent to carotid endarterectomy for stroke prevention; however, patients with ICA occlusion …